Every August, Community Health Centers across the country are recognized for the critical care they provide—especially to ...

England’s National Health Service (NHS) has stopped prescribing puberty blockers for children and young people with gender dysphoria or gender incongruence, saying there is “not enough ...

England's National Health Service banned the use of puberty blockers for children seeking treatment for gender dysphoria, citing limited research. Puberty blockers, or gonadotropin-releasing ...

A National Treasure, Tarnished: Can Britain Fix Its Health Service? As it turns 75, the N.H.S., a proud symbol of Britain’s welfare state, is in the deepest crisis of its history.

Topline Puberty blockers will no longer be prescribed to minors under age 18 in England outside of regulated clinical trials, the country’s National Health Service announced Tuesday, following ...

The National Health Service said Friday that “outside of a research setting, puberty-suppressing hormones should not be routinely commissioned for children and adolescents.” ...

Trusted partners and experts for clients navigating the New York State of Health Marketplace join AmeriLife’s growing Health Distribution network CLEARWATER, FL / ACCESS Newswire / August 6, 2025 / GS ...

The National Health Service said Palantir had been awarded the seven-year contract, worth 330 million pounds, or about $415 million, to build a new platform that integrates data from across the N ...

Hospital doctors in England began a five-day strike in a long-running dispute over pay, but the National Health Service vowed to keep disruption to a minimum.